Variant report
Variant | esv3439094 |
---|---|
Chromosome Location | chr2:190852495-190889473 |
allele | n/a |
Outlinks | Ensembl   UCSC |
- TF binding region (count:0)
- CpG islands (count:0)
- Chromatin interactive region (count:3)
- LncRNA region (count:0)
- Mature miRNA region (count: 0)
- miRNA target sites (count:0)
No data |
No data |
(count:3 , 50 per page) page:
1
No data |
No data |
No data |
No data |
No. | Variant name | Chromosome position | Chromatin state | Related regulatory elements | Target genes | Extended variants | Associated traits |
---|---|---|---|---|---|---|---|
1 | rs185121659 | chr2:190861821-190861822 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
2 | rs150154694 | chr2:190861862-190861863 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
3 | rs577185012 | chr2:190861990-190861991 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
4 | rs541047016 | chr2:190862005-190862006 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
5 | rs559352919 | chr2:190862022-190862023 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
6 | rs189643691 | chr2:190862060-190862061 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
7 | rs138616096 | chr2:190862062-190862063 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
8 | rs200119733 | chr2:190862065-190862066 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
9 | rs563220050 | chr2:190862106-190862107 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
10 | rs531958133 | chr2:190862110-190862111 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
11 | rs550076927 | chr2:190862174-190862175 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
12 | rs550967730 | chr2:190866624-190866625 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
13 | rs199989801 | chr2:190866632-190866633 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
14 | rs114622690 | chr2:190866640-190866641 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
15 | rs555079861 | chr2:190866667-190866668 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
16 | rs567323975 | chr2:190866708-190866709 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
17 | rs374762038 | chr2:190866765-190866766 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
18 | rs557487223 | chr2:190866838-190866839 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
19 | rs528714765 | chr2:190866881-190866882 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
20 | rs75634465 | chr2:190867001-190867002 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
21 | rs192024818 | chr2:190867067-190867068 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
22 | rs145321786 | chr2:190867068-190867069 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
23 | rs558479791 | chr2:190867117-190867118 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
24 | rs182490804 | chr2:190867187-190867188 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
25 | rs540609029 | chr2:190867225-190867226 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
26 | rs562064223 | chr2:190867231-190867232 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
27 | rs574045877 | chr2:190867264-190867265 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
28 | rs370864042 | chr2:190867280-190867281 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
29 | rs7585739 | chr2:190867281-190867282 | Enhancers | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
30 | rs547150380 | chr2:190867296-190867297 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
31 | rs112650351 | chr2:190867300-190867301 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
32 | rs539512033 | chr2:190867308-190867309 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
33 | rs532959346 | chr2:190867339-190867340 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
34 | rs551305400 | chr2:190867392-190867393 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
35 | rs374122050 | chr2:190867399-190867400 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
36 | rs142157761 | chr2:190873888-190873889 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
37 | rs569581754 | chr2:190873890-190873891 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
38 | rs34806740 | chr2:190873911-190873912 | Weak transcription | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | mRNA abundance |
39 | rs146616520 | chr2:190873917-190873918 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
40 | rs546844370 | chr2:190873996-190873997 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
41 | rs139116054 | chr2:190874005-190874006 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
42 | rs116659419 | chr2:190874007-190874008 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
43 | rs76780263 | chr2:190874066-190874067 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
44 | rs75912157 | chr2:190874099-190874100 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
45 | rs189397357 | chr2:190874108-190874109 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
46 | rs538479478 | chr2:190874167-190874168 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
47 | rs113414915 | chr2:190874191-190874192 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
48 | rs556735387 | chr2:190874299-190874300 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
49 | rs548195202 | chr2:190874341-190874342 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
50 | rs555897612 | chr2:190874347-190874348 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
Disease | PMID | Source |
---|---|---|
Breast cancer | 17603634 | CNVD |
Ewing''s sarcoma | 21437220 | CNVD |
Glioblastoma multiforme | 21080181 | CNVD |
Medulloblastoma | 21979893 | CNVD |
Ependymoma | 16718352 | CNVD |
Thoracic aortic aneurysm | 21092924 | CNVD |
Melanoma | 18172304 | CNVD |
Cancer | 16751803 | CNVD |
T-cell prolymphocytic leukemia | 19278963 | CNVD |
Acute lymphoblastic leukemia | 20067559 | CNVD |
Acute lymphoblastic leukemia | 21980252 | CNVD |
Testicular germ cell tumor | 18059402 | CNVD |
Breast cancer | 16272173 | CNVD |
Ewing''s sarcoma | 17952124 | CNVD |
Cancer | 21637783 | CNVD |
Non-syndromic sensorineural hearing loss | 18471307 | CNVD |
Esophageal squamous carcinoma | 21637470 | CNVD |
Liposarcoma | 21253554 | CNVD |
Endometrial cancer | 22040021 | CNVD |
Breast cancer | 21264507 | CNVD |
Embryonal rhabdomyosarcoma | 16790082 | CNVD |
Autism | 16446308 | CNVD |
Autism | 19401682 | CNVD |
Colorectal cancer | 16272173 | CNVD |
Hodgkin''s lymphoma | 17606441 | CNVD |
Lung cancer | 18438408 | CNVD |
Glioblastoma | 21080181 | CNVD |
Prostate cancer | 18632612 | CNVD |
Acute myeloid leukemia | 20729466 | CNVD |
small cell lung cancer | 20016488 | CNVD |
Facial dysmorphism | 20548289 | CNVD |
Mental retardation | 20548289 | CNVD |
Biliary cancer | 20360734 | CNVD |
Breast cancer | 20360734 | CNVD |
Coronary artery disease | 20360734 | CNVD |
Crohn''s disease | 20360734 | CNVD |
Hypertension | 20360734 | CNVD |
Rheumatoid arthritis | 20360734 | CNVD |
Type 1 diabetes | 20360734 | CNVD |
Type 2 diabetes | 20360734 | CNVD |
Breast cancer | 21364760 | CNVD |
Hirschsprung''s Disease | 21712996 | CNVD |
Cancer | 21183584 | CNVD |
Ovarian cancer | 21720365 | CNVD |
Immune disease | 21076436 | CNVD |
Immune disease | 21042300 | CNVD |
Colorectal cancer | 16912164 | CNVD |
Breast cancer | 22522925 | CNVD |
Cancer | 20164919 | CNVD |
Cancer | 17440070 | CNVD |
No. | Chromosome Location | Chromatin state | Cell line | Tissue |
---|---|---|---|---|
1 | chr2:190861800-190862200 | Enhancers | Fetal Muscle Leg | muscle |
2 | chr2:190866600-190867400 | Enhancers | Fetal Adrenal Gland | Adrenal Gland |
3 | chr2:190873800-190875000 | Weak transcription | Muscle Satellite Cultured Cells | -- |
4 | chr2:190875000-190875400 | Enhancers | Muscle Satellite Cultured Cells | -- |
5 | chr2:190883600-190883800 | ZNF genes & repeats | Aorta | Aorta |
6 | chr2:190884400-190893000 | Weak transcription | H1 BMP4 Derived Mesendoderm Cultured Cells | ES cell derived |